| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 75.94B | 54.19B | 50.41B | 48.62B | 47.01B |
| Gross Profit | 20.30B | 30.99B | 23.01B | 25.91B | 24.84B |
| EBITDA | 34.55B | 34.20B | 30.41B | 29.42B | 28.42B |
| Net Income | 24.12B | 23.85B | 20.30B | 19.29B | 17.17B |
Balance Sheet | |||||
| Total Assets | 729.96B | 730.53B | 727.23B | 714.90B | 707.55B |
| Cash, Cash Equivalents and Short-Term Investments | 50.24B | 27.06B | 36.01B | 58.91B | 31.25B |
| Total Debt | 329.95B | 328.75B | 323.85B | 313.40B | 304.43B |
| Total Liabilities | 371.59B | 370.46B | 366.43B | 354.56B | 344.29B |
| Stockholders Equity | 358.37B | 360.08B | 360.80B | 360.34B | 363.26B |
Cash Flow | |||||
| Free Cash Flow | -1.04B | -12.42B | 11.11B | 8.04B | -13.88B |
| Operating Cash Flow | 30.91B | 28.92B | 27.74B | 26.58B | 22.17B |
| Investing Cash Flow | -10.77B | -17.08B | -14.05B | -10.84B | -19.19B |
| Financing Cash Flow | -25.10B | -19.91B | -9.33B | -13.40B | -11.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥364.55B | 17.54 | 6.80% | 5.16% | -27.00% | 18.03% | |
75 Outperform | ¥567.93B | 12.42 | ― | 4.28% | 5.70% | 18.14% | |
67 Neutral | ¥330.55B | 23.38 | 5.35% | 4.18% | 2.53% | 1.49% | |
66 Neutral | ¥399.16B | 21.18 | 7.08% | 3.74% | -6.29% | 21.95% | |
66 Neutral | ¥654.75B | 10.14 | 5.51% | 4.64% | 50.40% | -30.38% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥560.64B | 23.41 | 6.80% | 4.46% | -0.32% | 1.93% |